Acetaminophen Price In USA

United States: 4965 USD/MT

In Q4 2023, the price of acetaminophen in the United States reached 4,965 USD/MT in December.

The latest report by IMARC Group, titled " Acetaminophen Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data," provides a thorough examination of Acetaminophen Prices. This report delves into the price of acetaminophen globally, presenting a detailed analysis, along with informative price chart. Through comprehensive price analysis, the report sheds light on the key factors influencing these trends. Additionally, it includes historical data to offer context and depth to the current pricing landscape. The report also explores the demand, analyzing how it impacts market dynamics. To aid in strategic planning, the price forecast section provides insights into price forecast, making this report an invaluable resource for industry stakeholders.

Acetaminophen Prices Analysis

China: 4751 USD/MT
Germany: 5034 USD/MT

Report Offering:

Monthly Updates - Annual Subscription
Quarterly Updates - Annual Subscription
Biannually Updates - Annual Subscription

The study delves into the factors affecting acetaminophen price variations, including alterations in the cost of raw materials, the balance of supply and demand, geopolitical influences, and sector-specific developments.

The report also incorporates the most recent updates from the market, equipping stakeholders with the latest information on market fluctuations, regulatory modifications, and technological progress. It serves as an exhaustive resource for stakeholders, enhancing strategic planning and forecast capabilities.

Acetaminophen Price Trend Last Quarter

The acetaminophen market is expanding steadily, driven by the rising demand from the healthcare industry. In line with this, the rising prevalence of chronic diseases like cancer has increased the demand for acetaminophen as an effective pain management solution. Healthcare providers are increasingly recommending non-opioid analgesics, with acetaminophen becoming a preferred option due to its safer profile amidst concerns over the opioid crisis.

In response, pharmaceutical companies are expanding their product portfolios to include more acetaminophen-based offerings to meet this growing demand, which is aiding in market expansion. Additionally, the aging global population and a higher incidence of pain-related conditions, such as arthritis are also fuelling the market expansion. Apart from this, favorable governments and healthcare organizations promoting non-addictive pain relief alternatives have led to a surge in acetaminophen usage, creating a positive outlook.

Acetaminophen Industry Analysis

In the last quarter, acetaminophen prices showed varied trends in the U.S., where prices increased due to disruptions in raw material supply chains, primarily from logistical issues like the Panama Canal drought, which delayed shipments and raised transportation costs. Besides this, the rising production costs for pharmaceutical companies also impacted consumers. Meanwhile, in China, the government enacted measures to regulate the prices of essential drugs like acetaminophen to combat inflation. Although prices were slightly lower than in other regions, high demand pushed prices up by the end of the quarter. In contrast, Germany saw a hike in acetaminophen prices, largely due to economic stabilization and regulatory pressures from the European Union (EU).

The EU Commission's investigation into price-fixing allegations created tension, resulting in temporary price spikes as companies adapted to regulatory scrutiny. Additionally, inflationary pressures across Europe increased production costs, particularly for raw materials, driving the prices up. In the Asia-Pacific region, rising healthcare costs and inflation prompted government intervention to control prices for essential medicines like acetaminophen, although high demand kept prices relatively stable. Furthermore, supply chain disruptions and rising manufacturing costs in Europe, particularly in countries like Germany and the Netherlands contributed to steady price increases.

Geopolitical factors, including tensions affecting global trade routes, complicated pricing dynamics in the region. Regulatory actions in the pharmaceutical sector also led to fluctuations in pricing trends as governments aimed to balance affordability with market profitability. Apart from this, varying economic conditions and regulatory policies also influenced acetaminophen price trends across these regions.

Regional Price Analysis:

Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece
North America: United States and Canada
Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru
Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco

Note: The current country list is selective, detailed insights into additional countries can be obtained for clients upon request.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145